+1 800 783 4636


Trace Elements and Electrocytes.(1994) Volume 1, Issue 4. P.182-186.
Comparative retention/absorption of 51chromium (51Cr) from 51Cr chloride, 51Cr nicotinate and 51Cr picolinate in a rat model
K. L. Olin ; D. M. Stearns ; W. H. Armstrong ; C. L. Keen


Recently, there has been a renewed interest in better defining the metabolism of chromium (Cr) with respect to both its absorption and cellular action. In the current study we investigated the absorption/retention of 3 Cr(III) compounds (Cr chloride [CrCl], Cr nicotinate [CrNic], Cr picolinate [CrPic]) over a 12 h period in a rat model. Male rats (150 – 170 g) were gavaged with 44 μCi (2.7 nmoles) 51Cr as CrCl3 x 6H2O, CrNic or CrPic. Rats were killed at 1, 3, 6, and 12 h post-gavage. Cardiac blood was collected and liver, kidneys, pancreas, testes, and gastrocnemius were removed, weighed and assayed for 51Cr. The amount of51Cr in these tissues, along with that in urine (collected for the 6 and 12 h groups), was used to calculate 51Cr absorbed/retained. Urine, followed by muscle and blood, had the highest percent of absorbed/retained counts. For the majority of the time points and tissues, the average percent 51Cr retained was higher in CrNic-gavaged rats than in CrCl- or CrPic-gavaged rats. Tissues collected 1 h post-gavage from CrNic rats had retention percentages that were 3.2 to 8.4- fold higher than in the CrPic or CrCl groups. Three h post-gavage, CrNic rats had blood, muscle, and pancreatic 51C tentions that were 2.4 to 8 times higher than CrPic-gavaged rats. By 6 and 12 h post-gavage, the ‘absorbed/retained’ tissues were 1.8 to 3.8 times higher in CrNic than in CrPic rats. It is evident from the above that when investigating the absorption/retention of Cr, it is critical to evaluate urinary 51Cr activity, which reflects absorbed Cr, and early time points. The results show that there can be significant differences in the bioavailabillty of different Cr compounds.


Recent Posts

Sorry, the comment form is closed at this time.

Terms of Use

This is business-to-business information intended for food and supplement producers, and is not intended for the final consumer. This information is based on our own research and development work and is, to the best of our knowledge, reliable. However, Lonza does not assume any liability or risk involved in the use of this information, as conditions of use are beyond our control. Manufacturers should check local regulatory status of any claims according to the intended use of their products.

Privacy and Cookies Notice


Please note that Lonza has updated its Privacy Policy. By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy Policy.


We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. Please read our updated Cookies Policy for information about which cookies we use and the information we collect. By continuing to use this website, you agree that we may store and access cookies on your device.


By clicking "I Agree", you confirm that you are above the age of 16, that you have read and understood the Privacy Policy and the Cookies Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policies.